4.8 Article

Highly sensitive and specific cytosensing of HT 29 colorectal cancer cells using folic acid functionalized-KCC-1 nanoparticles

期刊

BIOSENSORS & BIOELECTRONICS
卷 132, 期 -, 页码 122-131

出版社

ELSEVIER ADVANCED TECHNOLOGY
DOI: 10.1016/j.bios.2019.02.052

关键词

Differentiation; Folate bioreceptor; Cytosensor; Colon cancer; Fibrous nano-silica; Point of care

资金

  1. Liver and Gastrointestinal Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
  2. Ministry of Health and Medical Education (Iran) [700]

向作者/读者索取更多资源

Functionalized fibrous nano-silica (KCC-1) was applied to specific electrochemical detection of HT 29 colorectal cancer cells based on folate (FA)/folate receptor (FR) interactions. KCC-1 fibrous materials were synthesized using a hydrothermal method and then functionalized with FA molecules to produce KCC-1-NH2-FA nano particles. The KCC-1-NH2-FA fibrous nanoparticles offer favorable bleaching stability and exceptional surface area to volume ratio which provide facility to design more sensitive cytosensors. The morphology, size and surface charge of KCC-1, KCC-1-NH2 and KCC-1-NH2-FA were approved by field emission scanning electron microscope (FESEM), transmission electron microscopy (TEM), dynamic light scattering (DLS) and zeta potential, respectively. The porosity of the negatively charged KCC-1-NH2-FA was also tested with Brunauer-Emmett-Teller (BET) which approves the high surface area to volume ratio of the KCC-1 based materials. Flow cytometry and fluorescence imaging were applied to approve quantitative and qualitative attaching of KCC-1-NH2-FA to the HT 29 FR-positive cancer cells. Also, the specific capturing of the nanoparticles were approved by FR negative HEK 293 normal cells as FR-negative cells through cellular uptake assay which showed the smart differentiation by KCC-1-NH2-FA nanomaterials. The cytotoxicity results revealed the biocompatible nature of KCC-1 based materials, implying that the developed method could be used in in vivo applications under the optimized conditions. The developed cytosensor response is linear from 50 to 1.2 x 10(4) cells/mL with a lower limit of detection (LLOQ) of 50 cells/mL. As advantage of the developed cytosensor is simple and provides excellent specificity and sensitivity which enables us to design point of care devices for clinical uses.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据